These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. An open-label study of mirtazapine as treatment for combat-related PTSD. Alderman CP; Condon JT; Gilbert AL Ann Pharmacother; 2009 Jul; 43(7):1220-6. PubMed ID: 19584388 [TBL] [Abstract][Full Text] [Related]
4. Use of low-dose fluoxetine in major depression and panic disorder. Louie AK; Lewis TB; Lannon RA J Clin Psychiatry; 1993 Nov; 54(11):435-8. PubMed ID: 8270588 [TBL] [Abstract][Full Text] [Related]
5. Open trial of nefazodone for combat veterans with posttraumatic stress disorder. Garfield DA; Fichtner CG; Leveroni C; Mahableshwarkar A J Trauma Stress; 2001 Jul; 14(3):453-60. PubMed ID: 11534877 [TBL] [Abstract][Full Text] [Related]
6. Fluoxetine in posttraumatic stress disorder. van der Kolk BA; Dreyfuss D; Michaels M; Shera D; Berkowitz R; Fisler R; Saxe G J Clin Psychiatry; 1994 Dec; 55(12):517-22. PubMed ID: 7814344 [TBL] [Abstract][Full Text] [Related]
7. Treating comorbid panic disorder in veterans with posttraumatic stress disorder. Teng EJ; Bailey SD; Chaison AD; Petersen NJ; Hamilton JD; Dunn NJ J Consult Clin Psychol; 2008 Aug; 76(4):704-10. PubMed ID: 18665698 [TBL] [Abstract][Full Text] [Related]
8. Fluoxetine efficacy in social phobia. Van Ameringen M; Mancini C; Streiner DL J Clin Psychiatry; 1993 Jan; 54(1):27-32. PubMed ID: 8428894 [TBL] [Abstract][Full Text] [Related]
9. Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSD. David D; De Faria L; Mellman TA Depress Anxiety; 2006; 23(8):489-91. PubMed ID: 16845653 [TBL] [Abstract][Full Text] [Related]
10. Affective and anxiety comorbidity in post-traumatic stress disorder treatment trials of sertraline. Brady KT; Clary CM Compr Psychiatry; 2003; 44(5):360-9. PubMed ID: 14505296 [TBL] [Abstract][Full Text] [Related]
11. An open-label trial of nefazodone in high comorbidity panic disorder. DeMartinis NA; Schweizer E; Rickels K J Clin Psychiatry; 1996 Jun; 57(6):245-8. PubMed ID: 8666561 [TBL] [Abstract][Full Text] [Related]
12. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS]. Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547 [TBL] [Abstract][Full Text] [Related]
13. Fluoxetine in the acute treatment and relapse prevention of combat-related post-traumatic stress disorder: Analysis of the veteran group of a placebo-controlled, randomized clinical trial. Martenyi F; Soldatenkova V Eur Neuropsychopharmacol; 2006 Jul; 16(5):340-9. PubMed ID: 16356696 [TBL] [Abstract][Full Text] [Related]
14. A couple-based approach to the reduction of PTSD avoidance symptoms: preliminary findings. Sautter FJ; Glynn SM; Thompson KE; Franklin L; Han X J Marital Fam Ther; 2009 Jul; 35(3):343-9. PubMed ID: 19522786 [TBL] [Abstract][Full Text] [Related]
15. Outcome assessment and clinical improvement in panic disorder: evidence from a randomized controlled trial of fluoxetine and placebo. The Fluoxetine Panic Disorder Study Group. Michelson D; Lydiard RB; Pollack MH; Tamura RN; Hoog SL; Tepner R; Demitrack MA; Tollefson GD Am J Psychiatry; 1998 Nov; 155(11):1570-7. PubMed ID: 9812120 [TBL] [Abstract][Full Text] [Related]
17. Divalproex in the treatment of posttraumatic stress disorder: a randomized, double-blind, placebo-controlled trial in a veteran population. Davis LL; Davidson JR; Ward LC; Bartolucci A; Bowden CL; Petty F J Clin Psychopharmacol; 2008 Feb; 28(1):84-8. PubMed ID: 18204347 [TBL] [Abstract][Full Text] [Related]
18. Divalproex in posttraumatic stress disorder: an open-label clinical trial. Clark RD; CaƱive JM; Calais LA; Qualls CR; Tuason VB J Trauma Stress; 1999 Apr; 12(2):395-401. PubMed ID: 10378177 [TBL] [Abstract][Full Text] [Related]
19. Discriminative delay Pavlovian eyeblink conditioning in veterans with and without posttraumatic stress disorder. Ginsberg JP; Ayers E; Burriss L; Powell DA J Anxiety Disord; 2008 Jun; 22(5):809-23. PubMed ID: 17913453 [TBL] [Abstract][Full Text] [Related]
20. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder. Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]